NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered peptides from XTP? Mail in a sample (US only) and let us test it.

Test my supply
52%
Finnrick rating
#482 of 500 ranked vendors
9 of 19 classifiable tests passed
methodology · Purity focus
Finnrick analysis

XTP's purity-focus record is mixed, with Tesamorelin supported by a single pass and BPC-157 showing limited but mostly passing evidence. The larger Retatrutide record is weaker and dispersed, as early high-purity passes give way to recent XTP-R30-003 purity failures and one large underfill, so confidence is constrained by uneven volume.

methodology →
vendor intelligence report
Vendor Intelligence Report: XTP

XTP’s public trail runs through a privacy-protected Lithuanian domain, an unverified Xi’an company name, and a forum handoff after a representative account was banned. The report checks the Janoshik claim, warehouse context, and identity-failure dispute without overstating customs links.

16 pages4 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
BPC-157
$1.40
53%
3
2
Retatrutide
$0.75
53%
15
3
Tesamorelin
$2.00
51%
1
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%15 Jan 2026: 77%22 Jan 2026: 78%26 Jan 2026: 59%26 Jan 2026: 60%28 Apr 2026: 64%28 Apr 2026: 65%6 May 2026: 67%8 May 2026: 68%16 Jun 2026: 65%3 Aug 2026: 59%3 Aug 2026: 60%9 Sep 2026: 58%18 Sep 2026: 57%18 Sep 2026: 56%18 Sep 2026: 55%18 Sep 2026: 54%20 Sep 2026: 53%20 Sep 2026: 52%28 Oct 2026: 51%17 Nov 2026: current 52%77%65%52%Jan 26Nov 26
Peptide testing

Ordered peptides from XTP? Mail in a sample (US only) and let us test it.

Test my supply
XTP test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
28 Oct 2026
Fail
Retatrutide
lab nameView COA
20 Sep 2026
Fail
Retatrutide
lab nameView COA
20 Sep 2026
Fail
Retatrutide
lab nameView COA
18 Sep 2026
Fail
Retatrutide
lab nameView COA
18 Sep 2026
Fail
Retatrutide
lab nameView COA
18 Sep 2026
Fail
Retatrutide
lab nameView COA
18 Sep 2026
Fail
Retatrutide
lab nameView COA
9 Sep 2026
Fail
Retatrutide
lab nameView COA
3 Aug 2026
Pass
Retatrutide
lab nameView COA
3 Aug 2026
Pass
Tesamorelin
lab nameView COA
1-10 of 19

About XTP test results from Finnrick

XTP is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 3 peptides and 19 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible XTP peptides in this dataset are Retatrutide (15 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 19 recent tests.

Corrections
No corrections.
Peptide testing

Ordered peptides from XTP? Mail in a sample (US only) and let us test it.

Test my supply